-76% Off

Buy Xultophy Prefilled Pen from Canada

Original price was: $1,427.12.Current price is: $340.99.

Category: Insulin

Description
Additional information

Description

100 mg/3.6 mL

5 Pens

Xultophy marries the benefits of Insulin Degludec, a long-acting basal insulin, with Liraglutide, a GLP-1 receptor agonist. Both active ingredients are derived using the recombinant DNA expression of Saccharomyces cerevisiae. The solution, clear and colorless, is housed in a 3mL single-patient-use, pre-filled pen, with each mL containing 100 units of Insulin Degludec and 3.6mg of Liraglutide.

Additional information

Introduction	Introduction -Xultophy is formulated with two primary components: Insulin degludec, a long-lasting basal insulin, and Liraglutide, an active GLP-1 receptor agonist. Both of these ingredients are derived through the recombinant DNA process from Saccharomyces cerevisiae. This medication comes as a transparent, colorless liquid in a 3mL pre-filled pen designed for single-patient use. Each mL contains 100 units of Insulin degludec and 3.6mg of Liraglutide.
Usage	Usage: -Administer Xultophy once daily through a subcutaneous injection. Before use, check the pen for any discoloration or visible particles. This medication is dosed in steps, with the pen capable of delivering 1 to 50 steps in a single injection, increasing by one step at a time. To minimize the chances of skin conditions like cutaneous amyloidosis and lipodystrophy, always alternate the injection sites. Do not exceed a daily dosage of 50 steps, equivalent to 50 units of Insulin degludec and 1.8mg of Liraglutide.
Side Effects	Side Effects While many patients benefit from Xultophy without issues, some might experience side effects. Common side effects include: • Hypoglycemia • Nausea or vomiting • Diarrhea • Reduced appetite • Injection site reactions Consult a medical professional if you experience severe side effects or symptoms not listed here.
Storage	Storage • Keep Xultophy out of reach of children and pets. • Store in a refrigerator between 36°F to 46°F before first use. • After the initial use, Xultophy pens can be kept at room temperature (not exceeding 86°F) or refrigerated, ensuring it's kept away from direct light. • Always keep the pen cap on when not in use to protect from light. • If the medicine has undergone freezing, it must not be utilized.
Warnings, Precautions, and Contraindications	Warnings, Precautions, and Contraindications -Xultophy is not suitable for patients with Type 1 Diabetes Mellitus or those undergoing treatment for diabetic ketoacidosis. It's also not advised for individuals with a family lineage of Multiple Endocrine Neoplasia syndrome type 2 or Medullary thyroid cancer. There have been reports of acute renal failure and the deterioration of existing chronic renal failure following the use of Liraglutide. Adjusting the dose and vigilant monitoring of blood sugar levels is essential since certain medications can interfere with glucose regulation. Medications with Liraglutide may also result in slower gastric emptying.